TCI Wealth Advisors’s Halozyme HALO Stock Holding History

TCI Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-477	Closed	-$18.2K	–	1052
2023 Q1	$18.2K	Buy	477 +36	+8%	+$1.69K	﹤0.01%	763
2022 Q4	$25.1K	Buy	441 +1	+0.2%	+$51	﹤0.01%	599
2022 Q3	$17K	Buy	440 +6	+1%	+$265	﹤0.01%	731
2022 Q2	$19K	Hold	434	–	–	﹤0.01%	657
2022 Q1	$17K	Hold	434	–	–	﹤0.01%	764
2021 Q4	$17K	Buy	434 +197	+83%	+$7.35K	﹤0.01%	785
2021 Q3	$10K	Buy	237 +155	+189%	+$6.48K	﹤0.01%	1105
2021 Q2	$4K	Sell	82 -66	-45%	-$2.92K	﹤0.01%	1577
2021 Q1	$6K	Buy	148 +146	+7,300%	+$6.67K	﹤0.01%	1145
2020 Q4	$0	Buy	+2	New	+$72	﹤0.01%	1584
2015 Q2	–	Sell	-500	Closed	-$7K	–	976
2015 Q1	$7K	Buy	+500	New	+$7.21K	﹤0.01%	512

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

TCI Wealth Advisors's HALO Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Halozyme (HALO) in Q2 2023, closing a stake of 477 shares — an estimated $18.2K sold.

TCI Wealth Advisors first reported a position in HALO in Q1 2015 and held it in 11 quarters. The position peaked at $25.1K in Q4 2022. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.

TCI Wealth Advisors reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 477 Halozyme shares in Q2 2023, an estimated $18.2K.
TCI Wealth Advisors first reported a position in Halozyme in Q1 2015 and held it in 11 quarters.
TCI Wealth Advisors's Halozyme position peaked at $25.1K in Q4 2022.
370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.